1. Lee AJ, Wang JJ, Rochtchina E, et al. Patterns of glaucomatous visual field defects in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003; 31:331–335.
2. Boden C, Hoffmann EM, Medeiros FA, et al. Intereye concordance in locations of visual field defects in primary open-angle glaucoma: diagnostic innovations in glaucoma study. Ophthalmology. 2006; 113:918–923.
3. Chen PP, Bhandari A. Fellow eye prognosis in patients with severe visual field loss in 1 eye from chronic open-angle glaucoma. Arch Ophthalmol. 2000; 118:473–478.
4. Chen PP. Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology. 2002; 109:2093–2099.
5. Asman P, Heijl A. Glaucoma hemifield test: automated visual field evaluation. Arch Ophthalmol. 1992; 110:812–819.
6. Ederer F, Gaasterland DE, Sullivan EK. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials. 1994; 15:299–325.
7. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). 4. Comparison of treatment outcomes within race: seven-year results. Ophthalmology. 1998; 105:1146–1164.
8. Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci. 2000; 41:2201–2204.
9. Caprioli J, Mock D, Bitrian E, et al. A method to measure and predict rates of regional visual field decay in glaucoma. Invest Ophthalmol Vis Sci. 2011; 52:4765–4773.
10. Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J Educ Behav Stat. 2002; 27:77–83.
11. Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing;2010.
12. Heijl A, Lindgren G, Olsson J, Asman P. Visual field interpretation with empiric probability maps. Arch Ophthalmol. 1989; 107:204–208.
13. Heijl A, Leske MC, Bengtsson B, et al. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003; 81:286–293.
14. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996; 37:1419–1428.
15. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Comparison of methods to detect visual field progression in glaucoma. Ophthalmology. 1997; 104:1228–1236.
16. Nouri-Mahdavi K, Caprioli J, Coleman AL, et al. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol. 2005; 123:193–199.
17. Katz J, Gilbert D, Quigley HA, Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997; 104:1017–1025.
18. Chauhan BC, Drance SM, Douglas GR. The use of visual field indices in detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sci. 1990; 31:512–520.
19. Wild JM, Hussey MK, Flanagan JG, Trope GE. Pointwise topographical and longitudinal modeling of the visual field in glaucoma. Invest Ophthalmol Vis Sci. 1993; 34:1907–1916.
20. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989; 108:130–135.
21. Schulzer M. Errors in the diagnosis of visual field progression in normal-tension glaucoma. Ophthalmology. 1994; 101:1589–1594.
22. Kim J, Dally LG, Ederer F, et al. The Advanced Glaucoma Intervention Study (AGIS). 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology. 2004; 111:2109–2116.
23. Wall M, Woodward KR, Doyle CK, Artes PH. Repeatability of automated perimetry: a comparison between standard automated perimetry with stimulus size III and V, matrix, and motion perimetry. Invest Ophthalmol Vis Sci. 2009; 50:974–979.
24. Azarbod P, Mock D, Bitrian E, et al. Validation of pointwise exponential regression to measure the decay rates of glaucomatous visual fields. Invest Ophthalmol Vis Sci. 2012; 53:5403–5409.
25. Spry PG, Sparrow JM, Diamond JP, Harris HS. Risk factors for progressive visual field loss in primary open angle glaucoma. Eye. 2005; 19:643–651.
26. Pascual JP, Schiefer U, Paetzold J, et al. Spatial characteristics of visual field progression determined by Monte Carlo simulation: diagnostic innovations in glaucoma study. Invest Ophthalmol Vis Sci. 2007; 48:1642–1650.
27. Boden C, Blumenthal EZ, Pascual J, et al. Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol. 2004; 138:1029–1036.
28. Mikelberg FS, Drance SM. The mode of progression of visual field defects in glaucoma. Am J Ophthalmol. 1984; 98:443–445.